56 results
8-K
EX-1.1
EQ
Equillium Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:28pm
or investigation brought by or before any governmental entity now pending or, to the knowledge of the Company, threatened, against or affecting the Company or any … , hearing, enforcement, investigation, arbitration or other action from the Applicable Regulatory
Authorities or any other third party alleging that any
424B3
yc8p7lhrraltq7i1qtp
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
a2p9von
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
3xd4jj3
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
ook7ob8kq5bsv2
28 Sep 22
Business combination disclosure
6:01am
425
7adwhxv9ylbj6d6
27 Sep 22
Business combination disclosure
9:30am
8-K
EX-99.1
37p c8eg80per
27 Sep 22
Other Events
9:28am
425
5sggcwb
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-2.1
clph1agvvrbq
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-99.1
ubu 4im7f31w1da
12 May 22
Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates
4:07pm